Search

Tomer Granot

from Sarasota, FL
Age ~48
Get Report
Connected to:
Moshe Granot, 76Marc Granovitz, 73Michael D Granovitz, 54Glen T Granovsky, 62Olga Granovsky, 44Vitaly Granovsky, 63Eugene E Granowicz, 75Judy A Granowicz, 67Allyson Granowski, 60Andrew C Granquist, 46

Tomer Granot Phones & Addresses

  • Sarasota, FL
  • New York, NY
  • San Francisco, CA
  • Burlingame, CA
  • Mountain View, CA
  • Brooklyn, NY

Work

Company: Parvus therapeutics inc Jul 2019 Position: Senior scientist

Education

Degree: Doctorates, Doctor of Philosophy School / High School: New York University School of Medicine 2011 to 2011

Skills

Flow Cytometry • Immunology • Molecular Cloning • Tissue Culture • In Vivo • Oncology • Virology • Vaccines • Cell Therapy • T Cells • In Vivo Imaging • Immunotherapy • Transgenic Mice • Elisa • Lung Cancer • Dendritic Cells • Cytotoxicity • Nk Cells • Cytokines • Il 12 • Macrophages • Molecular Biology • Laboratory Skills • Biology • Cell Biology • Scientific Writing • Fluorescence Microscopy • Immunohistochemistry • Immuno Oncology • Drug Development • Biologics • Myeloid Cells • Ex Vivo • In Vitro

Languages

English • Hebrew

Industries

Biotechnology

Resumes

Resumes

Tomer Granot Photo 1

Immunologist

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Parvus Therapeutics Inc
Senior Scientist
Compugen Inc Sep 2017 - Mar 2019
Scientist Ii
Columbia University Medical Center Jul 2017 - Sep 2017
Associate Research Scientist
Columbia University Medical Center Mar 2014 - Jun 2017
Postdoctoral Research Scientist
Nyu Langone Medical Center May 2011 - Feb 2014
Postdoctoral Fellow
Education:
New York University School of Medicine 2011 - 2011
Doctorates, Doctor of Philosophy Tel Aviv University 2002 - 2002
Bachelors, Bachelor of Science
Skills:
Flow Cytometry
Immunology
Molecular Cloning
Tissue Culture
In Vivo
Oncology
Virology
Vaccines
Cell Therapy
T Cells
In Vivo Imaging
Immunotherapy
Transgenic Mice
Elisa
Lung Cancer
Dendritic Cells
Cytotoxicity
Nk Cells
Cytokines
Il 12
Macrophages
Molecular Biology
Laboratory Skills
Biology
Cell Biology
Scientific Writing
Fluorescence Microscopy
Immunohistochemistry
Immuno Oncology
Drug Development
Biologics
Myeloid Cells
Ex Vivo
In Vitro
Languages:
English
Hebrew

Publications

Us Patents

Method For Inducing Antitumor Immunity Using Sindbis Viral Vectors And Tumor Associated Antigens

View page
US Patent:
20190000994, Jan 3, 2019
Filed:
Jun 1, 2018
Appl. No.:
15/996271
Inventors:
- New York NY, US
Tomer Granot - Brooklyn NY, US
Yoshihide Yamanashi - Brooklyn NY, US
International Classification:
A61K 48/00
A61K 39/00
Abstract:
The subject application is directed to a method for treating a mammal harboring a tumor comprising identifying a tumor associated antigen (TAA) expressed by the tumor and parenterally administering to the mammal a therapeutically effective amount of a Sindbis viral vector carrying a gene encoding the TAA to the mammal sufficient to elicit an immune response directed against the tumor, and thereby treating the tumor.

Tumor Therapy With Antitumor Agents In Combination With Sindbis Virus-Based Vectors

View page
US Patent:
20160008431, Jan 14, 2016
Filed:
Jul 13, 2015
Appl. No.:
14/798077
Inventors:
- New York NY, US
Tomer Granot - Brooklyn NY, US
Jen-Chieh Tseng - Canton MA, US
International Classification:
A61K 38/18
A61K 31/337
Abstract:
A method for treating malignant tumors with Sindbis viral based vectors in combination with antitumor agents and pharmaceutical formulations for use in such treatment.

Method For Inducing Antitumor Immunity Using Sindbis Viral Vectors And Tumor Associated Antigens

View page
US Patent:
20150071882, Mar 12, 2015
Filed:
Sep 5, 2014
Appl. No.:
14/478783
Inventors:
- New York NY, US
Tomer Granot - Brooklyn NY, US
Yoshihide Yamanashi - Brooklyn NY, US
International Classification:
A61K 48/00
C12N 15/86
US Classification:
424 932
Abstract:
The subject application is directed to a method for treating a mammal harboring a tumor comprising identifying a tumor associated antigen (TAA) expressed by the tumor and parenterally administering to the mammal a therapeutically effective amount of a Sindbis viral vector carrying a gene encoding the TAA to the mammal sufficient to elicit an immune response directed against the tumor, and thereby treating the tumor.
Control profile
Tomer Granot from Sarasota, FL, age ~48 Get Report